By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Pharmaceuticals4.75B46.24%
devices2.44B23.76%
Over-the-counter (OTC)2.01B19.56%
Branded and Other Generics962M9.37%
Other revenues110M1.07%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.6.14B59.79%
Other1.15B11.23%
Other724M7.05%
China493M4.80%
Canada417M4.06%
Poland382M3.72%
Mexico278M2.71%
France249M2.43%
South Korea234M2.28%
Russia198M1.93%
View all